{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:42:07Z","timestamp":1780450927545,"version":"3.54.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National College Students\u2019 Innovative Entrepreneurial Training Plan Program","award":["202310730177"],"award-info":[{"award-number":["202310730177"]}]},{"name":"The Excellence Program Project for students of the First Clinical Medical School of Lanzhou University","award":["20220060003"],"award-info":[{"award-number":["20220060003"]}]},{"name":"Medical Innovation and Development Project of Lanzhou University","award":["Izuyxcx-2022-175"],"award-info":[{"award-number":["Izuyxcx-2022-175"]}]},{"name":"Science Foundation of the First Hospital of Lanzhou University","award":["ldyyyn2023-30"],"award-info":[{"award-number":["ldyyyn2023-30"]}]},{"DOI":"10.13039\/501100004775","name":"the Natural Science Foundation of Gansu Province, China","doi-asserted-by":"crossref","award":["25JRRA1008"],"award-info":[{"award-number":["25JRRA1008"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19932-5","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:18:35Z","timestamp":1760527115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bioinformatics analysis of the expression of TRIM31 mRNA and protein in pan-cancer tissues and their prognostic relevance"],"prefix":"10.1038","volume":"15","author":[{"given":"Yujie","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"19932_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. C Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"C Cancer J. Clin."},{"key":"19932_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ccell.2020.05.021","volume":"38","author":"S Srivastava","year":"2020","unstructured":"Srivastava, S. & Hanash, S. Pan-cancer early detection: Hype or hope? Cancer Cell. 38, 23\u201324. https:\/\/doi.org\/10.1016\/j.ccell.2020.05.021 (2020).","journal-title":"Cancer Cell."},{"key":"19932_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C. & Lordick, F. Gastric cancer. Lancet 396, 635\u2013648. https:\/\/doi.org\/10.1016\/S0140-6736(20)31288-5 (2020).","journal-title":"Lancet"},{"key":"19932_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.23750\/abm.v89i8-S.7897","volume":"89","author":"P Fugazzola","year":"2018","unstructured":"Fugazzola, P. et al. Advanced gastric cancer: The value of surgery. Acta Biomed. 89, 110\u2013116. https:\/\/doi.org\/10.23750\/abm.v89i8-S.7897 (2018).","journal-title":"Acta Biomed."},{"key":"19932_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/annonc\/mdw040","volume":"27","author":"NY Chia","year":"2016","unstructured":"Chia, N. Y. & Tan, P. Molecular classification of gastric cancer. Ann. Oncol. 27, 763\u2013769. https:\/\/doi.org\/10.1093\/annonc\/mdw040 (2016).","journal-title":"Ann. Oncol."},{"key":"19932_CR6","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S2468-1253(21)00313-7","volume":"6","author":"RH Xu","year":"2021","unstructured":"Xu, R. H. et al. Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): A randomised, multicentre, double-blind, phase 3 trial. Lancet Gastroenterol. Hepatol. 6, 1015\u20131024. https:\/\/doi.org\/10.1016\/S2468-1253(21)00313-7 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"19932_CR7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/bies.20304","volume":"27","author":"G Meroni","year":"2005","unstructured":"Meroni, G. & Diez-Roux, G. TRIM\/RBCC, a novel class of \u2018single protein ring finger\u2019 E3 ubiquitin ligases. BioEssays 27, 1147\u20131157. https:\/\/doi.org\/10.1002\/bies.20304 (2005).","journal-title":"BioEssays"},{"key":"19932_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41419-021-04208-3","volume":"12","author":"Y Guo","year":"2021","unstructured":"Guo, Y. et al. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53. Cell. Death Dis. 12, 945. https:\/\/doi.org\/10.1038\/s41419-021-04208-3 (2021).","journal-title":"Cell. Death Dis."},{"key":"19932_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41392-021-00711-3","volume":"6","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. TRIM31 facilitates K27-linked polyubiquitination of SYK to regulate antifungal immunity. Signal. Transduct. Target. Ther. 6, 298. https:\/\/doi.org\/10.1038\/s41392-021-00711-3 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"19932_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ni.3641","volume":"18","author":"B Liu","year":"2017","unstructured":"Liu, B. et al. The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination. Nat. Immunol. 18, 214\u2013224. https:\/\/doi.org\/10.1038\/ni.3641 (2017).","journal-title":"Nat. Immunol."},{"key":"19932_CR11","doi-asserted-by":"publisher","first-page":"13727","DOI":"10.1038\/ncomms13727","volume":"7","author":"H Song","year":"2016","unstructured":"Song, H. et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat. Commun. 7, 13727. https:\/\/doi.org\/10.1038\/ncomms13727 (2016).","journal-title":"Nat. Commun."},{"key":"19932_CR12","doi-asserted-by":"publisher","first-page":"11726","DOI":"10.1038\/ncomms11726","volume":"7","author":"EA Ra","year":"2016","unstructured":"Ra, E. A. et al. TRIM31 promotes Atg5\/Atg7-independent autophagy in intestinal cells. Nat. Commun. 7, 11726. https:\/\/doi.org\/10.1038\/ncomms11726 (2016).","journal-title":"Nat. Commun."},{"key":"19932_CR13","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/jcb.21908","volume":"105","author":"T Sugiura","year":"2008","unstructured":"Sugiura, T. & Miyamoto, K. Characterization of TRIM31, upregulated in gastric adenocarcinoma, as a novel RBCC protein. J. Cell. Biochem. 105, 1081\u20131091. https:\/\/doi.org\/10.1002\/jcb.21908 (2008).","journal-title":"J. Cell. Biochem."},{"key":"19932_CR14","doi-asserted-by":"publisher","first-page":"1047177","DOI":"10.3389\/fonc.2022.1047177","volume":"12","author":"Y Guo","year":"2022","unstructured":"Guo, Y., Lin, P., Hua, Y. & Wang, C. TRIM31: A molecule with a dual role in cancer. Front. Oncol. 12, 1047177. https:\/\/doi.org\/10.3389\/fonc.2022.1047177 (2022).","journal-title":"Front. Oncol."},{"key":"19932_CR15","doi-asserted-by":"publisher","first-page":"687102","DOI":"10.3389\/fimmu.2021.687102","volume":"12","author":"X Jia","year":"2021","unstructured":"Jia, X., Zhao, C. & Zhao, W. Emerging roles of MHC class I region-encoded E3 ubiquitin ligases in innate immunity. Front. Immunol. 12, 687102. https:\/\/doi.org\/10.3389\/fimmu.2021.687102 (2021).","journal-title":"Front. Immunol."},{"key":"19932_CR16","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416. https:\/\/doi.org\/10.1016\/j.cell.2018.02.052 (2018).","journal-title":"Cell"},{"key":"19932_CR17","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"19932_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. K. E. G. G. Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"19932_CR19","doi-asserted-by":"publisher","unstructured":"Bonneville, R. et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis. Oncol. 1, 1\u201315. https:\/\/doi.org\/10.1200\/PO.17.00073 (2017).","DOI":"10.1200\/PO.17.00073"},{"key":"19932_CR20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812\u2013830e14. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023 (2018).","journal-title":"Immunity"},{"key":"19932_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta, T. M. et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell 173, 338\u2013354e15. https:\/\/doi.org\/10.1016\/j.cell.2018.03.034 (2018).","journal-title":"Cell"},{"key":"19932_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.canlet.2021.08.020","volume":"520","author":"L Jiang","year":"2021","unstructured":"Jiang, L. et al. Bcl2-associated athanogene 4 promotes the invasion and metastasis of gastric cancer cells by activating the PI3K\/AKT\/NF-\u03baB\/ZEB1 axis. Cancer Lett. 520, 409\u2013421. https:\/\/doi.org\/10.1016\/j.canlet.2021.08.020 (2021).","journal-title":"Cancer Lett."},{"issue":"1","key":"19932_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-019-1186-z","volume":"38","author":"L Jiang","year":"2019","unstructured":"Jiang, L. et al. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFN\u03b3\/STAT1 signaling. J. Exp. Clin. Cancer Res.: CR. 38(1), 206. https:\/\/doi.org\/10.1186\/s13046-019-1186-z (2019).","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"19932_CR24","doi-asserted-by":"publisher","first-page":"20099","DOI":"10.1038\/s41598-023-47139-z","volume":"13","author":"Q Feng","year":"2023","unstructured":"Feng, Q. et al. Tripartite motif 31 drives gastric cancer cell proliferation and invasion through activating the Wnt\/\u03b2-catenin pathway by regulating Axin1 protein stability. Sci. Rep. 13, 20099. https:\/\/doi.org\/10.1038\/s41598-023-47139-z (2023).","journal-title":"Sci. Rep."},{"key":"19932_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40164-022-00322-w","volume":"11","author":"N Huang","year":"2022","unstructured":"Huang, N. et al. TRIM family contribute to tumorigenesis, cancer development, and drug resistance. Exp. Hematol. Oncol. 11, 75. https:\/\/doi.org\/10.1186\/s40164-022-00322-w (2022).","journal-title":"Exp. Hematol. Oncol."},{"key":"19932_CR26","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.7150\/thno.23259","volume":"8","author":"C Yu","year":"2018","unstructured":"Yu, C., Chen, S., Guo, Y. & Sun, C. Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-\u03baB signaling pathway. Theranostics 8, 3224\u20133236. https:\/\/doi.org\/10.7150\/thno.23259 (2018).","journal-title":"Theranostics"},{"key":"19932_CR27","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/onc.2017.349","volume":"37","author":"P Guo","year":"2018","unstructured":"Guo, P. et al. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex. Oncogene 37, 478\u2013488. https:\/\/doi.org\/10.1038\/onc.2017.349 (2018).","journal-title":"Oncogene"},{"key":"19932_CR28","first-page":"1836","volume":"37","author":"B Xu","year":"2021","unstructured":"Xu, B., Li, Y., Liu, M. & Liu, Y. Silencing TRIM31 gene expression suppresses bladder cancer cells migration and invasion by regulating Wnt\/\u03b2-catenin signaling pathway. Chin. J. Immunol. 37, 1836\u20131840 (2021).","journal-title":"Chin. J. Immunol."},{"key":"19932_CR29","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.cell.2012.04.026","volume":"149","author":"T Li","year":"2012","unstructured":"Li, T. et al. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 149, 1269\u20131283. https:\/\/doi.org\/10.1016\/j.cell.2012.04.026 (2012).","journal-title":"Cell"},{"key":"19932_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yexcr.2018.04.013","volume":"368","author":"P Guo","year":"2018","unstructured":"Guo, P. et al. Tripartite motif 31 promotes resistance to anoikis of hepatocarcinoma cells through regulation of p53-AMPK axis. Exp. Cell. Res. 368, 59\u201366. https:\/\/doi.org\/10.1016\/j.yexcr.2018.04.013 (2018).","journal-title":"Exp. Cell. Res."},{"key":"19932_CR31","first-page":"1247","volume":"10","author":"H Wang","year":"2018","unstructured":"Wang, H., Yao, L., Gong, Y. & Zhang, B. TRIM31 regulates chronic inflammation via NF-\u03baB signal pathway to promote invasion and metastasis in colorectal cancer. Am. J. Transl Res. 10, 1247\u20131259 (2018).","journal-title":"Am. J. Transl Res."},{"key":"19932_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4149\/neo_2019_190106N21","volume":"66","author":"G Shi","year":"2019","unstructured":"Shi, G. et al. TRIM31 promotes proliferation, invasion and migration of glioma cells through Akt signaling pathway. Neoplasma 66, 727\u2013735. https:\/\/doi.org\/10.4149\/neo_2019_190106N21 (2019).","journal-title":"Neoplasma"},{"key":"19932_CR33","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3892\/etm.2020.8782","volume":"20","author":"MD Fan","year":"2020","unstructured":"Fan, M. D. et al. TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K\/Akt signaling pathway. Exp. Ther. Med. 20, 802\u2013809. https:\/\/doi.org\/10.3892\/etm.2020.8782 (2020).","journal-title":"Exp. Ther. Med."},{"key":"19932_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","volume":"32","author":"J Liu","year":"2022","unstructured":"Liu, J., Peng, Y. & Wei, W. Cell cycle on the crossroad of tumorigenesis and cancer therapy. Trends Cell. Biol. 32, 30\u201344. https:\/\/doi.org\/10.1016\/j.tcb.2021.07.001 (2022).","journal-title":"Trends Cell. Biol."},{"key":"19932_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. & Wang, X. Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer. J. Hematol. Oncol. 13, 165. https:\/\/doi.org\/10.1186\/s13045-020-00990-3 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"19932_CR36","doi-asserted-by":"publisher","first-page":"8179","DOI":"10.2147\/OTT.S215769","volume":"12","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. Knockdown of TRIM31 enhances colorectal cancer radiosensitivity by inducing DNA damage and activating apoptosis. Onco Targets Ther. 12, 8179\u20138188. https:\/\/doi.org\/10.2147\/OTT.S215769 (2019).","journal-title":"Onco Targets Ther."},{"key":"19932_CR37","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.1007\/s13277-014-1763-x","volume":"35","author":"H Li","year":"2014","unstructured":"Li, H. et al. TRIM31 is downregulated in non-small cell lung cancer and serves as a potential tumor suppressor. Tumour Biol. 35, 5747\u20135752. https:\/\/doi.org\/10.1007\/s13277-014-1763-x (2014).","journal-title":"Tumour Biol."},{"key":"19932_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.gene.2014.10.021","volume":"554","author":"JA Mauro","year":"2015","unstructured":"Mauro, J. A., Butler, S. N., Ramsamooj, M. & Blanck, G. Copy number loss or silencing of apoptosis-effector genes in cancer. Gene 554, 50\u201357. https:\/\/doi.org\/10.1016\/j.gene.2014.10.021 (2015).","journal-title":"Gene"},{"key":"19932_CR39","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/onc.2015.209","volume":"35","author":"L Liang","year":"2016","unstructured":"Liang, L., Fang, J. Y. & Xu, J. Gastric cancer and gene copy number variation: Emerging cancer drivers for targeted therapy. Oncogene 35, 1475\u20131482. https:\/\/doi.org\/10.1038\/onc.2015.209 (2016).","journal-title":"Oncogene"},{"issue":"1","key":"19932_CR40","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1186\/s12885-017-3851-y","volume":"17","author":"GD Cao","year":"2017","unstructured":"Cao, G. D. et al. Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients. BMC Cancer. 17(1), 841. https:\/\/doi.org\/10.1186\/s12885-017-3851-y (2017).","journal-title":"BMC Cancer"},{"key":"19932_CR41","doi-asserted-by":"publisher","unstructured":"Cao, G. D. et al. HER3, but not HER4, plays an essential role in the clinicopathology and prognosis of gastric cancer: A meta-analysis. PloS One. 11(8). https:\/\/doi.org\/10.1371\/journal.pone.0161219 (2016). e0161219.","DOI":"10.1371\/journal.pone.0161219"},{"key":"19932_CR42","doi-asserted-by":"publisher","first-page":"16224","DOI":"10.1073\/pnas.0808041105","volume":"105","author":"RJ Leary","year":"2008","unstructured":"Leary, R. J. et al. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc. Natl. Acad. Sci. U S A 105, 16224\u201316229. https:\/\/doi.org\/10.1073\/pnas.0808041105 (2008).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"19932_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ygyno.2014.09.014","volume":"135","author":"E Despierre","year":"2014","unstructured":"Despierre, E. et al. Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer. Gynecol. Oncol. 135, 415\u2013422. https:\/\/doi.org\/10.1016\/j.ygyno.2014.09.014 (2014).","journal-title":"Gynecol. Oncol."},{"key":"19932_CR44","doi-asserted-by":"publisher","first-page":"E578","DOI":"10.1002\/ijc.29215","volume":"136","author":"S Horpaopan","year":"2015","unstructured":"Horpaopan, S. et al. Genome-wide CNV analysis in 221 unrelated patients and targeted high-throughput sequencing reveal novel causative candidate genes for colorectal adenomatous polyposis. Int. J. Cancer 136, E578\u2013E589. https:\/\/doi.org\/10.1002\/ijc.29215 (2015).","journal-title":"Int. J. Cancer"},{"key":"19932_CR45","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.cell.2020.11.004","volume":"183","author":"V Roudko","year":"2020","unstructured":"Roudko, V. et al. Shared Immunogenic poly-epitope frameshift mutations in microsatellite unstable tumors. Cell 183, 1634\u20131649e17. https:\/\/doi.org\/10.1016\/j.cell.2020.11.004 (2020).","journal-title":"Cell"},{"key":"19932_CR46","doi-asserted-by":"publisher","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","volume":"362","author":"R Cristescu","year":"2018","unstructured":"Cristescu, R. et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science 362, eaar3593. https:\/\/doi.org\/10.1126\/science.aar3593 (2018).","journal-title":"Science"},{"key":"19932_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","volume":"39","author":"DL Jardim","year":"2021","unstructured":"Jardim, D. L., Goodman, A., de Melo Gagliato, D. & Kurzrock, R. The challenges of tumor mutational burden as an immunotherapy biomarker. Cancer Cell. 39, 154\u2013173. https:\/\/doi.org\/10.1016\/j.ccell.2020.10.001 (2021).","journal-title":"Cancer Cell."},{"key":"19932_CR48","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202\u2013209. https:\/\/doi.org\/10.1038\/nature13480 (2014).","journal-title":"Nature"},{"key":"19932_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jare.2022.10.019","volume":"51","author":"Y Cheng","year":"2023","unstructured":"Cheng, Y. et al. Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer. J. Adv. Res. 51, 121\u2013134. https:\/\/doi.org\/10.1016\/j.jare.2022.10.019 (2023).","journal-title":"J. Adv. Res."},{"key":"19932_CR50","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/annonc\/mdz197","volume":"30","author":"F Wang","year":"2019","unstructured":"Wang, F. et al. Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase ib\/ii clinical trial NCT02915432. Ann. Oncol. 30, 1479\u20131486. https:\/\/doi.org\/10.1093\/annonc\/mdz197 (2019).","journal-title":"Ann. Oncol."},{"key":"19932_CR51","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1158\/1078-0432.CCR-22-0121","volume":"28","author":"KW Lee","year":"2022","unstructured":"Lee, K. W. et al. Association of tumor mutational burden with efficacy of pembrolizumab\u2009\u00b1\u2009chemotherapy as first-line therapy for gastric cancer in the phase III KEYNOTE-062 study. Clin. Cancer Res. 28, 3489\u20133498. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-0121 (2022).","journal-title":"Clin. Cancer Res."},{"key":"19932_CR52","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano, L., Jord\u0101o, M. J. C. & Joyce, J. A. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 11, 933\u2013959. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1808 (2021).","journal-title":"Cancer Discov."},{"key":"19932_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059 (2022).","journal-title":"Cancer Discov"},{"key":"19932_CR54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth, N., Wicha, M. S. & Zou, W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat. Rev. Immunol. 17, 559\u2013572. https:\/\/doi.org\/10.1038\/nri.2017.49 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"19932_CR55","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta, L. & Pollard, J. W. Targeting macrophages: Therapeutic approaches in cancer. Nat. Rev. Drug Discov.  17, 887\u2013904. https:\/\/doi.org\/10.1038\/nrd.2018.169 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"19932_CR56","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. & Allavena, P. Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"19932_CR57","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","volume":"27","author":"B Ruffell","year":"2015","unstructured":"Ruffell, B. & Coussens, L. M. Macrophages and therapeutic resistance in cancer. Cancer Cell. 27, 462\u2013472. https:\/\/doi.org\/10.1016\/j.ccell.2015.02.015 (2015).","journal-title":"Cancer Cell."},{"key":"19932_CR58","doi-asserted-by":"publisher","first-page":"1016817","DOI":"10.3389\/fimmu.2022.1016817","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Li, C., Lu, Y., Liu, C. & Yang, W. Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer. Front. Immunol. 13, 1016817. https:\/\/doi.org\/10.3389\/fimmu.2022.1016817 (2022).","journal-title":"Front. Immunol."},{"key":"19932_CR59","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","volume":"19","author":"MJ Pittet","year":"2022","unstructured":"Pittet, M. J., Michielin, O. & Migliorini, D. Clinical relevance of tumour-associated macrophages. Nat. Rev. Clin. Oncol. 19, 402\u2013421. https:\/\/doi.org\/10.1038\/s41571-022-00620-6 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"19932_CR60","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3892\/ol.2018.9703","volume":"17","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Macrophages activate mesenchymal stem cells to acquire cancer-associated fibroblast-like features resulting in gastric epithelial cell lesions and malignant transformation in vitro. Oncol. Lett. 17, 747\u2013756. https:\/\/doi.org\/10.3892\/ol.2018.9703 (2019).","journal-title":"Oncol. Lett."},{"key":"19932_CR61","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.trecan.2022.12.007","volume":"9","author":"N Guti\u00e9rrez-Melo","year":"2023","unstructured":"Guti\u00e9rrez-Melo, N. & Baumjohann, D. T follicular helper cells in cancer. Trends Cancer. 9, 309\u2013325. https:\/\/doi.org\/10.1016\/j.trecan.2022.12.007 (2023).","journal-title":"Trends Cancer"},{"key":"19932_CR62","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","volume":"184","author":"C Cui","year":"2021","unstructured":"Cui, C. et al. Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell 184, 6101\u20136118e13. https:\/\/doi.org\/10.1016\/j.cell.2021.11.007 (2021).","journal-title":"Cell"},{"key":"19932_CR63","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.cell.2019.10.028","volume":"179","author":"DP Hollern","year":"2019","unstructured":"Hollern, D. P. et al. B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer. Cell 179, 1191\u20131206e21. https:\/\/doi.org\/10.1016\/j.cell.2019.10.028 (2019).","journal-title":"Cell"},{"key":"19932_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","volume":"14","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. NK cell-based cancer immunotherapy: From basic biology to clinical development. J. Hematol. Oncol. 14, 7. https:\/\/doi.org\/10.1186\/s13045-020-01014-w (2021).","journal-title":"J. Hematol. Oncol."},{"key":"19932_CR65","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","volume":"19","author":"N Shimasaki","year":"2020","unstructured":"Shimasaki, N., Jain, A. & Campana, D. NK cells for cancer immunotherapy. Nat. Rev. Drug Discov. 19, 200\u2013218. https:\/\/doi.org\/10.1038\/s41573-019-0052-1 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"19932_CR66","doi-asserted-by":"publisher","first-page":"e927464","DOI":"10.12659\/MSM.927464","volume":"27","author":"MZ Xie","year":"2021","unstructured":"Xie, M. Z. et al. Percentage of natural killer (NK) cells in peripheral blood is associated with prognosis in patients with gastric cancer: a retrospective study from a single center. Med. Sci. Monit. 27, e927464. https:\/\/doi.org\/10.12659\/MSM.927464 (2021).","journal-title":"Med. Sci. Monit."},{"key":"19932_CR67","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/ijc.28780","volume":"135","author":"K Mimura","year":"2014","unstructured":"Mimura, K. et al. Therapeutic potential of highly cytotoxic natural killer cells for gastric cancer. Int. J. Cancer. 135, 1390\u20131398. https:\/\/doi.org\/10.1002\/ijc.28780 (2014).","journal-title":"Int. J. Cancer"},{"key":"19932_CR68","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1038\/onc.2015.324","volume":"35","author":"R Xing","year":"2016","unstructured":"Xing, R. et al. Copy number variations of HLA-I and activation of NKp30 pathway determine the sensitivity of gastric cancer cells to the cytotoxicity of natural killer cells. Oncogene 35, 2584\u20132591. https:\/\/doi.org\/10.1038\/onc.2015.324 (2016).","journal-title":"Oncogene"},{"key":"19932_CR69","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.3390\/cancers12123605","volume":"12","author":"A Anichini","year":"2020","unstructured":"Anichini, A., Perotti, V. E., Sgambelluri, F. & Mortarini, R. Immune escape mechanisms in non small cell lung cancer. Cancers 12, 3605. https:\/\/doi.org\/10.3390\/cancers12123605 (2020).","journal-title":"Cancers"},{"key":"19932_CR70","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","volume":"271","author":"DR Leach","year":"1996","unstructured":"Leach, D. R., Krummel, M. F. & Allison, J. P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734\u20131736. https:\/\/doi.org\/10.1126\/science.271.5256.1734 (1996).","journal-title":"Science"},{"key":"19932_CR71","doi-asserted-by":"publisher","first-page":"111186","DOI":"10.1016\/j.intimp.2023.111186","volume":"126","author":"M Patwekar","year":"2024","unstructured":"Patwekar, M. et al. Novel immune checkpoint targets: A promising therapy for cancer treatments. Int. Immunopharmacol. 126, 111186. https:\/\/doi.org\/10.1016\/j.intimp.2023.111186 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"19932_CR72","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41577-023-00867-9","volume":"23","author":"K Chamoto","year":"2023","unstructured":"Chamoto, K., Yaguchi, T., Tajima, M. & Honjo, T. Insights from a 30-year journey: Function, regulation and therapeutic modulation of PD1. Nat. Rev. Immunol. 23, 682\u2013695. https:\/\/doi.org\/10.1038\/s41577-023-00867-9 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"19932_CR73","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.2147\/OTT.S282319","volume":"14","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Exosomes derived from pancreatic cancer cells induce osteoclast differentiation through the miR125a-5p\/TNFRSF1B pathway. OncoTargets Therapy 14, 2727\u20132739. https:\/\/doi.org\/10.2147\/OTT.S282319 (2021).","journal-title":"OncoTargets Therapy"},{"key":"19932_CR74","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.gene.2018.09.052","volume":"681","author":"A Ku\u015fo\u011flu","year":"2019","unstructured":"Ku\u015fo\u011flu, A. & Biray Avc\u0131, \u00c7. Cancer stem cells: A brief review of the current status. Gene 681, 80\u201385. https:\/\/doi.org\/10.1016\/j.gene.2018.09.052 (2019).","journal-title":"Gene"},{"key":"19932_CR75","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1158\/0008-5472.CAN-12-4136","volume":"73","author":"K Shien","year":"2013","unstructured":"Shien, K. et al. Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells. Cancer Res. 73, 3051\u20133061. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-4136 (2013).","journal-title":"Cancer Res."},{"key":"19932_CR76","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12943-022-01682-x","volume":"21","author":"P Nallasamy","year":"2022","unstructured":"Nallasamy, P. et al. Tumor microenvironment enriches the stemness features: The architectural event of therapy resistance and metastasis. Mol. Cancer. 21, 225. https:\/\/doi.org\/10.1186\/s12943-022-01682-x (2022).","journal-title":"Mol. Cancer"},{"key":"19932_CR77","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254\u20131261. https:\/\/doi.org\/10.1126\/science.abf0529 (2022).","journal-title":"Science"},{"key":"19932_CR78","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","volume":"22","author":"J Xie","year":"2023","unstructured":"Xie, J., Yang, Y., Gao, Y. & He, J. Cuproptosis: Mechanisms and links with cancers. Mol. Cancer. 22, 46. https:\/\/doi.org\/10.1186\/s12943-023-01732-y (2023).","journal-title":"Mol. Cancer"},{"key":"19932_CR79","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13046-021-02031-4","volume":"40","author":"M Buccarelli","year":"2021","unstructured":"Buccarelli, M. et al. Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth. J. Exp. Clin. Cancer Res. 40, 228. https:\/\/doi.org\/10.1186\/s13046-021-02031-4 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"19932_CR80","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jhep.2020.12.031","volume":"74","author":"C Raggi","year":"2021","unstructured":"Raggi, C. et al. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma. J. Hepatol. 74, 1373\u20131385. https:\/\/doi.org\/10.1016\/j.jhep.2020.12.031 (2021).","journal-title":"J. Hepatol."},{"key":"19932_CR81","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou, E. D. et al. BCL-2 Inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell. Stem Cell. 12, 329\u2013341. https:\/\/doi.org\/10.1016\/j.stem.2012.12.013 (2013).","journal-title":"Cell. Stem Cell."},{"key":"19932_CR82","doi-asserted-by":"publisher","first-page":"BSR20194334","DOI":"10.1042\/BSR20194334","volume":"40","author":"Y Xiao","year":"2020","unstructured":"Xiao, Y., Deng, T., Ming, X. & Xu, J. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt\/\u03b2-catenin signaling. Biosci. Rep. 40, BSR20194334. https:\/\/doi.org\/10.1042\/BSR20194334 (2020).","journal-title":"Biosci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19932-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19932-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19932-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:03:40Z","timestamp":1760915020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19932-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19932"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19932-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36050"}}